- Patent Title: Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
-
Application No.: US15556694Application Date: 2016-03-09
-
Publication No.: US10526388B2Publication Date: 2020-01-07
- Inventor: Tomoya Miyakawa , Masaaki Oka , Shoichi Hazama , Koji Tamada , Keiko Udaka
- Applicant: CYTLIMIC INC.
- Applicant Address: JP Tokyo
- Assignee: Cytlimic Inc.
- Current Assignee: Cytlimic Inc.
- Current Assignee Address: JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP2015-046463 20150309
- International Application: PCT/JP2016/057356 WO 20160309
- International Announcement: WO2016/143816 WO 20160915
- Main IPC: C07K9/00
- IPC: C07K9/00 ; C07K14/47 ; A61K38/00 ; A61K39/00 ; C07K14/705 ; A61P37/04 ; A61P35/00 ; A61K38/17
Abstract:
The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 11 and consisting of 11 or less amino acid residues.
Public/Granted literature
Information query
